Real-time enrollment status for this systemic lupus erythematosus clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:50 AM UTC
| NCT Number | NCT05835310 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus |
| Phase | PHASE3 |
| Target Enrollment | 100 participants |
| Active Locations | 22 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | June 18, 2026 (4 weeks ago) |
As of July 17, 2026: Clinical trial NCT05835310 is currently recruiting participants. This phase3 study for systemic lupus erythematosus is actively seeking new participants at 22 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05835310 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05835310 was last updated 4 weeks ago (June 18, 2026). HelloStudys verifies this status automatically.